FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385759499> ?p ?o ?g. }

• W4385759499 endingPage "2265" @default.
• W4385759499 startingPage "2265" @default.
• W4385759499 abstract "Introduction: Multiple myeloma (MM) is the most common plasma cell tumor type. In late 2015, the FDA approved three new medications for MM. These medications were ixazomib, daratumumab, and elotuzumab. However, their utilization, reimbursement, and price in the Medicaid program have not been analyzed before. Methods: A retrospective drug utilization study using the national Medicaid pharmacy claims data from 2016 to 2022 in the US. The primary metrics of analysis were utilization (number of prescriptions), reimbursement (total spending), and price (reimbursement per prescription). Results: The overall Medicaid utilization of MM medications increased from 1671 prescriptions in 2016 to 34,583 prescriptions in 2022 (1970% increase). Moreover, the overall Medicaid reimbursement for the new MM medications increased from USD 9,250,000 in 2016 to over USD 214,449,000 in 2022 (2218% increase). Daratumumab had much higher utilization, reimbursement, and market shares than its competitors. Ixazomib was the most expensive medication compared to daratumumab and elotuzumab. Conclusion: The results of this study demonstrate that CMS utilization and spending on MM medications have significantly grown since 2016. Daratumumab has by far the highest utilization, spending, and market share. The utilization of and spending on specific pharmaceuticals are clearly impacted by policy and clinical guideline recommendations." @default.
• W4385759499 created "2023-08-12" @default.
• W4385759499 creator A5034053516 @default.
• W4385759499 creator A5036576235 @default.
• W4385759499 creator A5039096001 @default.
• W4385759499 creator A5059022695 @default.
• W4385759499 date "2023-08-11" @default.
• W4385759499 modified "2023-09-29" @default.
• W4385759499 title "Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022" @default.
• W4385759499 cites W132940748 @default.
• W4385759499 cites W1975698977 @default.
• W4385759499 cites W1987966072 @default.
• W4385759499 cites W2020298011 @default.
• W4385759499 cites W2091067403 @default.
• W4385759499 cites W2111060865 @default.
• W4385759499 cites W2182475191 @default.
• W4385759499 cites W2549396793 @default.
• W4385759499 cites W2555011614 @default.
• W4385759499 cites W2567188480 @default.
• W4385759499 cites W2591278923 @default.
• W4385759499 cites W2745820493 @default.
• W4385759499 cites W2948728876 @default.
• W4385759499 cites W2970922094 @default.
• W4385759499 cites W2985155145 @default.
• W4385759499 cites W3098173822 @default.
• W4385759499 cites W3119005666 @default.
• W4385759499 cites W3130937910 @default.
• W4385759499 cites W3139400676 @default.
• W4385759499 cites W3157357599 @default.
• W4385759499 cites W3160287786 @default.
• W4385759499 cites W3206192616 @default.
• W4385759499 cites W3213622034 @default.
• W4385759499 cites W4210616186 @default.
• W4385759499 cites W4210734847 @default.
• W4385759499 cites W4280556871 @default.
• W4385759499 cites W4293253058 @default.
• W4385759499 cites W4293798101 @default.
• W4385759499 cites W4320855879 @default.
• W4385759499 cites W4321435287 @default.
• W4385759499 doi "https://doi.org/10.3390/healthcare11162265" @default.
• W4385759499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37628464" @default.
• W4385759499 hasPublicationYear "2023" @default.
• W4385759499 type Work @default.
• W4385759499 citedByCount "0" @default.
• W4385759499 crossrefType "journal-article" @default.
• W4385759499 hasAuthorship W4385759499A5034053516 @default.
• W4385759499 hasAuthorship W4385759499A5036576235 @default.
• W4385759499 hasAuthorship W4385759499A5039096001 @default.
• W4385759499 hasAuthorship W4385759499A5059022695 @default.
• W4385759499 hasBestOaLocation W43857594991 @default.
• W4385759499 hasConcept C104863432 @default.
• W4385759499 hasConcept C126322002 @default.
• W4385759499 hasConcept C144133560 @default.
• W4385759499 hasConcept C160735492 @default.
• W4385759499 hasConcept C162118730 @default.
• W4385759499 hasConcept C162324750 @default.
• W4385759499 hasConcept C2426938 @default.
• W4385759499 hasConcept C2776063141 @default.
• W4385759499 hasConcept C2776291444 @default.
• W4385759499 hasConcept C2776364478 @default.
• W4385759499 hasConcept C2776534028 @default.
• W4385759499 hasConcept C2778858636 @default.
• W4385759499 hasConcept C2779703844 @default.
• W4385759499 hasConcept C2780108899 @default.
• W4385759499 hasConcept C2781098529 @default.
• W4385759499 hasConcept C2781119759 @default.
• W4385759499 hasConcept C50522688 @default.
• W4385759499 hasConcept C512399662 @default.
• W4385759499 hasConcept C71924100 @default.
• W4385759499 hasConcept C98274493 @default.
• W4385759499 hasConceptScore W4385759499C104863432 @default.
• W4385759499 hasConceptScore W4385759499C126322002 @default.
• W4385759499 hasConceptScore W4385759499C144133560 @default.
• W4385759499 hasConceptScore W4385759499C160735492 @default.
• W4385759499 hasConceptScore W4385759499C162118730 @default.
• W4385759499 hasConceptScore W4385759499C162324750 @default.
• W4385759499 hasConceptScore W4385759499C2426938 @default.
• W4385759499 hasConceptScore W4385759499C2776063141 @default.
• W4385759499 hasConceptScore W4385759499C2776291444 @default.
• W4385759499 hasConceptScore W4385759499C2776364478 @default.
• W4385759499 hasConceptScore W4385759499C2776534028 @default.
• W4385759499 hasConceptScore W4385759499C2778858636 @default.
• W4385759499 hasConceptScore W4385759499C2779703844 @default.
• W4385759499 hasConceptScore W4385759499C2780108899 @default.
• W4385759499 hasConceptScore W4385759499C2781098529 @default.
• W4385759499 hasConceptScore W4385759499C2781119759 @default.
• W4385759499 hasConceptScore W4385759499C50522688 @default.
• W4385759499 hasConceptScore W4385759499C512399662 @default.
• W4385759499 hasConceptScore W4385759499C71924100 @default.
• W4385759499 hasConceptScore W4385759499C98274493 @default.
• W4385759499 hasIssue "16" @default.
• W4385759499 hasLocation W43857594991 @default.
• W4385759499 hasLocation W43857594992 @default.
• W4385759499 hasOpenAccess W4385759499 @default.
• W4385759499 hasPrimaryLocation W43857594991 @default.
• W4385759499 hasRelatedWork W1266257458 @default.
• W4385759499 hasRelatedWork W2024818394 @default.
• W4385759499 hasRelatedWork W2044226452 @default.

• next